[DOI] [PubMed] [Google Scholar] 36.Kwon C.H., Kim W., Shin J.H., Lee C.J., Kim H.C., Kang S.H., Jung M.H., Kim D.H., Lee J.H., Kim H.L., et al
But the jump from C57BL/6 mice to humans involves differences in metabolic rate, NNMT tissue distribution, adipose tissue physiology, and drug metabolism that preclinical data cannot address
Telemedicine platforms and peptide therapy clinics across the country now include it in their treatment menus
However, it is disappointing that with the consumption of intracellular GSH, the cell produces a stress response to up-regulate the biosynthesis of GSH, which will cause intracellular GSH cannot be completely exhausted and cells become resistant to GSH-consuming drugs [14]